Search results for: 'test of use'

BFSI organizations are exploring ways to expand their business and boost the productivity of their employees while establishing closer relationships with their customers while delivering great products/ services. Digital transformation is really enabling BFSI organizations to unlock these outcomes. Extending this further, BFSI contact centers focus...

This study will benefit those who are interested in learning about how business models are evolving in the security industry and potential opportunities in this segment. It discusses the key aspects of security business models and identifies use cases in various types of service-based models being adopted to address security capability requirement ...

Today’s hypercompetitive business environment requires not only maintaining the highest levels of system availability, but capitalizing on unique differentiators like data. For most businesses, data—whether customer, research-driven, or market-based—is a concrete asset that is being leveraged in new and different ways, in activities such as product...

This research benchmarks top participants in the global lubricants industry. Lubricants are integral to the smooth operations of vehicles, equipment, and systems in the automotive and transportation, industrial, agricultural, and heavy equipment spaces. Lubricants are materials that are primarily used to reduce friction between two or more componen...

16 Dec 2019  |  Europe  |  Market Research

Strategic Analysis of the Electric Vehicle (EV) Ecosystem in Germany, 2018–2025

BEVs and PHEVs are Expected to Grow from 72,014 Unit Sales in 2018 to 880,017 Unit Sales in 2025 at a CAGR of about 43.0% during 2018–2025

Infographics

×

Key Issues Addressed

The automotive industry is rapidly evolving in terms of technology as well as tackling environmental issues. Electric vehicles have been introduced as a clean energy initiative as they have low or zero emissions and have come a long way to become an integral part of OEM’s business strategies. Automakers are creating separate EV business units to be...

Global lithium-ion battery market revenue is expected to increase at an impressive 17.9% compound annual growth rate from 2018 to 2025. Market growth is fueled by rising demand for energy storage around the world, electric vehicle production, and demand for industrial power tools and electric forklifts. Technological advancements have allowed batte...

09 Jan 2020  |  North America  |  Market Research

Analysis of the Global Cardiac Monitoring Market, Forecast to 2023

New Age Technology Poised to Change the Way Care is Delivered

Infographics

×

Key Issues Addressed

The cardiac monitoring market is at a juncture where classical point-of-care monitoring devices are being commoditized, while advances in the understanding of patient needs have resulted in upgraded versions of cardiac monitors entering the market. The classical point-of-care electrocardiogram, as a technology, is at a stage where innovation is foc...

31 Dec 2019  |  North America  |  Market Research

Global Biometrics Market, Forecast to 2024

eGovernance, Mobile Biometrics and eCommerce Drive the Ubiquity of Biometrics in Commercial and Government Applications

Infographics

×

The global biometrics market is at a high growth stage due to the ubiquity of dominant biometric modalities such as fingerprint and facial recognition. The deployment of biometrics is increasingly pervasive in both governmental and commercial sectors because of ease of use and the high degree of convenience offered by the technology. Key applicatio...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...